anmelden
OMX Nordic 40
2.622,16
PKT
+5,46
PKT
+0,21
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 29.02.16 | Ericsson (Telefon L.M.Ericsson) (B) Hold | Deutsche Bank AG | |
| 29.02.16 | Volvo (B) buy | UBS AG | |
| 26.02.16 | AstraZeneca Outperform | BNP PARIBAS | |
| 24.02.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 23.02.16 | Nokia kaufen | Norddeutsche Landesbank (Nord/LB) | |
| 22.02.16 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 22.02.16 | AstraZeneca buy | Jefferies & Company Inc. | |
| 19.02.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 18.02.16 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.02.16 | Nokia overweight | JP Morgan Chase & Co. | |
| 18.02.16 | Volvo (B) Neutral | Goldman Sachs Group Inc. | |
| 16.02.16 | Novo Nordisk Neutral | BNP PARIBAS | |
| 16.02.16 | Ericsson (Telefon L.M.Ericsson) (B) Equal-Weight | Morgan Stanley | |
| 15.02.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.02.16 | Nokia buy | UBS AG | |
| 12.02.16 | Nokia buy | S&P Capital IQ | |
| 12.02.16 | Nokia Outperform | BNP PARIBAS | |
| 12.02.16 | Nokia Outperform | Credit Suisse Group | |
| 11.02.16 | Nokia Halten | Independent Research GmbH | |
| 09.02.16 | Novo Nordisk Halten | Independent Research GmbH | |
| 09.02.16 | AstraZeneca buy | UBS AG | |
| 09.02.16 | ABB (Asea Brown Boveri) Underperform | BNP PARIBAS | |
| 08.02.16 | Volvo (B) buy | Citigroup Corp. | |
| 08.02.16 | AstraZeneca Halten | Independent Research GmbH | |
| 08.02.16 | Volvo (B) Underweight | JP Morgan Chase & Co. | |
| 08.02.16 | Novo Nordisk Sell | UBS AG | |
| 08.02.16 | AstraZeneca Hold | HSBC | |
| 05.02.16 | AstraZeneca buy | Deutsche Bank AG | |
| 05.02.16 | Volvo (B) Hold | S&P Capital IQ | |
| 05.02.16 | AstraZeneca buy | Société Générale Group S.A. (SG) | |
| 05.02.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 05.02.16 | AstraZeneca buy | UBS AG | |
| 05.02.16 | Ericsson (Telefon L.M.Ericsson) (B) buy | UBS AG | |
| 05.02.16 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
| 05.02.16 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 04.02.16 | AstraZeneca Hold | S&P Capital IQ | |
| 04.02.16 | Novo Nordisk overweight | Barclays Capital | |
| 04.02.16 | Novo Nordisk Neutral | UBS AG | |
| 04.02.16 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley |